Literature DB >> 20862503

Successful remission induction with a combination therapy of rituximab, cyclophosphamide, and steroids in a patient with refractory optic neuritis in Wegener's granulomatosis.

Cord Huchzermeyer1, Christian Mardin, Leonard Holbach, Jochen Zwerina, Georg Schett, Jürgen Rech.   

Abstract

A 56-year old patient with a history of limited Wegener's granulomatosis presented with signs and symptoms of optic neuritis. Radiologic signs of orbital inflammation were absent. Testing of visual acuity and visual field allowed close monitoring of disease activity. Thus, rapid improvement of visual function was achieved with high-dose steroids. Despite maintenance therapy with cyclophosphamide recurrence occurred repeatedly as soon as tapering of steroids was begun. After remission induction with rituximab, the patient retained good visual function under maintenance therapy with azathioprine and low-dose corticosteroids. Optic neuritis in Wegener's granulomatosis without signs of orbital involvement is rare and most likely caused by occlusive vasculitis of the vasa nervorum. In this patient with optic neuritis refractory to conventional therapy, rituximab in combination with cyclophosphamide and corticosteroids was well tolerated and successfully used for remission induction, followed by maintenance therapy with azathioprine and low dose corticosteroids.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20862503     DOI: 10.1007/s10067-010-1561-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  23 in total

Review 1.  From T to B and back again: positive feedback in systemic autoimmune disease.

Authors:  M J Shlomchik; J E Craft; M J Mamula
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

Review 2.  Vitamin D metabolite-mediated hypercalcemia in Wegener's granulomatosis.

Authors:  X Bosch; A López-Soto; A Morelló; A Olmo; A Urbano-Márquez
Journal:  Mayo Clin Proc       Date:  1997-05       Impact factor: 7.616

3.  Ocular changes in limited forms of Wegener's granulomatosis.

Authors:  D J Spalton; E M Graham; N G Page; M D Sanders
Journal:  Br J Ophthalmol       Date:  1981-08       Impact factor: 4.638

4.  [Wegener's granulomatosis: ocular manifestations, diagnosis and therapy].

Authors:  G Duncker; A Beigel; H Lehmann
Journal:  Klin Monbl Augenheilkd       Date:  1982-09       Impact factor: 0.700

5.  Bilateral optic neuritis in wegener granulomatosis.

Authors:  Mário Luiz Ribeiro Monteiro; Wander Inturias Sergillo Borges; Carolina do Val Ferreira Ramos; Leandro Tavares Lucato; Cláudia Costa Leite
Journal:  J Neuroophthalmol       Date:  2005-03       Impact factor: 3.042

6.  Effectiveness of rituximab in severe Wegener's granulomatosis: report of two cases and review of the literature.

Authors:  Joaquim Oristrell; Guillermina Bejarano; Rosa Jordana; Manuel Monteagudo; Begoña Marí; Arnau Casanovas; Carles Tolosa
Journal:  Open Respir Med J       Date:  2009-06-25

7.  A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.

Authors:  R W Beck; P A Cleary; M M Anderson; J L Keltner; W T Shults; D I Kaufman; E G Buckley; J J Corbett; M J Kupersmith; N R Miller
Journal:  N Engl J Med       Date:  1992-02-27       Impact factor: 91.245

8.  Ocular manifestations of classical and limited Wegener's granulomatosis.

Authors:  P Stavrou; J Deutsch; C Rene; D E Laws; R A Luqmani; P I Murray
Journal:  Q J Med       Date:  1993-11

Review 9.  Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee.

Authors:  G Anderson; E T Coles; M Crane; A C Douglas; A R Gibbs; D M Geddes; E T Peel; J B Wood
Journal:  Q J Med       Date:  1992-06

Review 10.  What you should know about PR3-ANCA. Evidence for the role of T cells in the pathogenesis of systemic vasculitis.

Authors:  A R Clayton; C O Savage
Journal:  Arthritis Res       Date:  2000-06-12
View more
  6 in total

1.  Outcomes of toll-like receptors' antagonism in steroid-resistant optic neuritis; a pilot study.

Authors:  Aditya Sudhalkar; Mayuri Khamar; Bakulesh Khamar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-15       Impact factor: 3.117

2.  Mycobacterium W administration for steroid resistant optic neuritis with long-term follow-up.

Authors:  Aditya Sudhalkar; Mayuri Khamar; Bakulesh Khamar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-09-18       Impact factor: 3.117

3.  Magnetic resonance imaging of optic nerve.

Authors:  Foram Gala
Journal:  Indian J Radiol Imaging       Date:  2015 Oct-Dec

4.  Successful Combination Therapy with Rituximab and Glucocorticoids for Autoimmune Optic Neuropathy.

Authors:  Shoichi Sasaki; Daisuke Asahara; Kaichi Kaneko; Satoru Komatsumoto
Journal:  Am J Case Rep       Date:  2015-06-09

5.  Current options for the treatment of optic neuritis.

Authors:  John H Pula; Christopher J Macdonald
Journal:  Clin Ophthalmol       Date:  2012-07-31

6.  Dynamic Immune Cell Recruitment After Murine Pulmonary Aspergillus fumigatus Infection under Different Immunosuppressive Regimens.

Authors:  Natarajaswamy Kalleda; Jorge Amich; Berkan Arslan; Spoorthi Poreddy; Katharina Mattenheimer; Zeinab Mokhtari; Hermann Einsele; Matthias Brock; Katrin Gertrud Heinze; Andreas Beilhack
Journal:  Front Microbiol       Date:  2016-07-13       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.